# Production Assistance for Cellular Therapies (PACT)- Cell Processing Facilities Cell manufacturing and process development services for RSA PCT0035-01: Preclinical Development of PB-derived iTregs

> **NIH NIH N01** · UNIVERSITY OF MINNESOTA · 2020 · $561,544

## Abstract

The objective of this project is to develop an optimized approach to isolation and expansion of peripheral blood-derived iTregs.

## Key facts

- **NIH application ID:** 10115183
- **Project number:** 268201600014I-0-759202000001-1
- **Recipient organization:** UNIVERSITY OF MINNESOTA
- **Principal Investigator:** DAVID MCKENNA
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $561,544
- **Award type:** —
- **Project period:** 2019-11-01 → 2020-10-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10115183

## Citation

> US National Institutes of Health, RePORTER application 10115183, Production Assistance for Cellular Therapies (PACT)- Cell Processing Facilities Cell manufacturing and process development services for RSA PCT0035-01: Preclinical Development of PB-derived iTregs (268201600014I-0-759202000001-1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10115183. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*